Tuesday, May 22, 2018 6:42:47 PM
The best response to that is to buy and hold, hold and hold. We’ve been here long enough to prove them WRONG.
The main focus now should be on the upcoming FDA full clearance of Actipatch for full body muscle and joint pain.
The second focus should be on May 29 meeting with the FDA and the licensing agreement with BAYER Dr. Scholl’s.
Remember that more than 99% of shares available are not being traded here and held by more than the 16,000 investors in Biel.
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM